Antibiotic resistance of Acinetobacter Baumanii isolated from children in Wuhan between 2006 and 2008.
- Author:
Tao YU
1
;
Lian-Sheng BAO
;
Lao-Rong YANG
;
Fang LIU
Author Information
- Publication Type:Journal Article
- MeSH: Acinetobacter baumannii; drug effects; Anti-Bacterial Agents; pharmacology; Child; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Time Factors
- From: Chinese Journal of Contemporary Pediatrics 2010;12(8):613-615
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the variance of antibiotic resistance of Acinetobacter Baumanii isolated from children in Wuhan between 2006 and 2008.
METHODSBacterial susceptibility testing was carried out by the Kirby-Bauer method in 679 strains of Acinetobacter Baumanii isolated in Wuhan Children's Hospital between 2006 and 2008. The results were assessed according to the guidelines of the Clinical and Laboratory Standards Institute (2008).
RESULTSThe nonsusceptible rates of Acinetobacter Baumanii to ceftazidime, cefepime and piperacillin/sulbactam increased significantly in 2007 compared with those in 2006 (P<0.05). By comparing the results of 2007, it was suggested that the nonsusceptible rates of Acinetobacter Baumanii to ceftazidime, cefepime, piperacillin/sulbactam, cefoperazone/sulbactam, imipenem and meropenem increased significantly in 2008 (P < 0.05).
CONCLUSIONSThe nonsusceptible rates of Acinetobacter Baumanii to beta-lactam antibiotics in children from Wuhan increased significantly year by year between 2006 and 2008.
